1. 42: A Competing Risk Analysis of Prognostic Factors for Local and Regional Recurrence and Survival Outcomes in Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy. (September 2022) Authors: Tonneau, Marion; Richard, Corentin; Routy, Bertrand; Campeau, Marie-Pierre; Vu, Toni; Filion, Edith; Roberge, David; Mathieu, Dominique; Doucet, Robert; Beliveau-Nadeau, Dominic; Bahig, Houda Journal: Radiotherapy and oncology Issue: Volume 174(2022)Supplement 1 Page Start: S20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 50: Prospective Neurocognitive Functions of Patients Treated with Concurrent Nivolumab and Stereotactic Brain Radiosurgery for NSCLC and RCC Brain Metastases. (October 2021) Authors: Masucci, Giuseppina Laura; Boucher, Olivier; Florescu, Marie; Plourde, Marc-Emile; Ménard, Cynthia; Masson-Côté, Laurence; Panet-Raymond, Valérie; Blais, Normand; Routy, Bertrand; Tehfé, Mustapha; Owen, Scott; Pavic, Michel; Roberge, David; Wong, Philip Journal: Radiotherapy and oncology Issue: Volume 163(2021)Supplement 1 Page Start: S24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 679 High fiber diet modifies gut microbiome, propionate production, intratumor immune response and is associated with outcome in patients with lung cancer treated with immune checkpoint inhibitors. (9th November 2020) Authors: Richard, Corentin; Benlaifaoui, Myriam; Ouarzadi, Omar El; Diop, Khoudia; Desilets, Antoine; Malo, Julie; Belkaid, Wiam; Leblanc, Andréanne; Lamontagne, Julien; Messaoudene, Meriem; Elkrief, Arielle; Routy, Bertrand Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A718 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 679 High fiber diet modifies gut microbiome, propionate production, intratumor immune response and is associated with outcome in patients with lung cancer treated with immune checkpoint inhibitors. (9th November 2020) Authors: Richard, Corentin; Benlaifaoui, Myriam; Ouarzadi, Omar El; Diop, Khoudia; Desilets, Antoine; Malo, Julie; Belkaid, Wiam; Leblanc, Andréanne; Lamontagne, Julien; Messaoudene, Meriem; Elkrief, Arielle; Routy, Bertrand Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A408 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 681 Single pipeline re-analysis revises microbiome associations with anti-tumor response to checkpoint inhibitors. (9th November 2020) Authors: Shaikh, Fyza; White, James; Gills, Joell; Hakozaki, Taiki; Corentin, Richard; Routy, Bertrand; Okuma, Yusuke; Usyk, Mykhaylo; Pandey, Abhishek; Weber, Jeffrey; Ahn, Jiyoung; Naidoo, Jarushka; Lipson, Evan; Pardoll, Drew; Sears, Cynthia Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A720 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 681 Single pipeline re-analysis revises microbiome associations with anti-tumor response to checkpoint inhibitors. (9th November 2020) Authors: Shaikh, Fyza; White, James; Gills, Joell; Hakozaki, Taiki; Corentin, Richard; Routy, Bertrand; Okuma, Yusuke; Usyk, Mykhaylo; Pandey, Abhishek; Weber, Jeffrey; Ahn, Jiyoung; Naidoo, Jarushka; Lipson, Evan; Pardoll, Drew; Sears, Cynthia Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Angiotensin-converting enzyme (ACE) inhibitor prescription affects non-small-cell lung cancer (NSCLC) patients response to PD-1/PD-L1 immune checkpoint blockers. (1st January 2020) Authors: Medjebar, Soleine; Truntzer, Caroline; Perrichet, Anaïs; Limagne, Emeric; Fumet, Jean-David; Richard, Corentin; Elkrief, Arielle; Routy, Bertrand; Rébé, Cédric; Ghiringhelli, François Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors. (3rd April 2019) Authors: Elkrief, Arielle; El Raichani, Layal; Richard, Corentin; Messaoudene, Meriem; Belkaid, Wiam; Malo, Julie; Belanger, Karl; Miller, Wilson; Jamal, Rahima; Letarte, Nathalie; Wong, Philip; Routy, Bertrand Journal: Oncoimmunology Issue: Volume 8:Number 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Arterial thrombosis and coronavirus disease 2019 in a patient with cancer. (July 2020) Authors: Nassabein, Rami; Routy, Bertrand; Blais, Normand; Ayoub, Jean-pierre; Tehfé, Mustapha Journal: European journal of cancer Issue: Volume 134(2020) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Camu Camu effects on microbial translocation and systemic immune activation in ART-treated people living with HIV: protocol of the single-arm non-randomised Camu Camu prebiotic pilot study (CIHR/CTN PT032). Issue 1 (17th January 2022) Authors: Isnard, Stéphane; Fombuena, Brandon; Ouyang, Jing; Royston, Léna; Lin, John; Bu, Simeng; Sheehan, Nancy; Lakatos, Peter L; Bessissow, Talat; Chomont, Nicolas; Klein, Marina; Lebouché, Bertrand; Costiniuk, Cecilia T; Routy, Bertrand; Marette, André; Routy, Jean-Pierre Journal: BMJ open Issue: Volume 12:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗